A052
De-identified Human Immune Atlas donor/sample detail for Neutrophil_LiverCancer_Nature_2022. The record preserves available public metadata while avoiding direct identifiers.
Primary Metadata
Core de-identified metadata fields migrated from the ImmuneAging donor manifest.
Donor ID
A052
Sample ID
A052_CHC
Dataset
Neutrophil_LiverCancer_Nature_2022
Cohort
Human liver cancer cohort, 124 patients
Age / Age Group
62 years
Sex
Female
Health Status
Combined hepatocellular and cholangiocarcinoma (CHC); TNM I; BCLC C
Tissue / Cell Source
tumor or liver lesion tissue; library IDs in Supplementary Table 1b: A052_HCC
Modality
scRNA-seq
Cell Count
6,238
Analysis Status
Published scRNA-seq
UMAP Status
Ready
Metadata / Source Notes
Source: Nature Supplementary Table 1a/1b; patient samples: A052_CHC; library samples: A052_HCC; no. PB samples: 0; no. adjacent liver samples: 0; no. tumor samples: 1; differentiation: Low-Moderate; venous invasion: 0; cirrhosis: 0
Additional Clinical / Source Fields
Supplementary source metadata retained from the migrated manifest where available.
cancer type
Combined hepatocellular and cholangiocarcinoma
cancer type short
CHC
tnm stage
I
bclc stage
C
virus
HCV
tumor size cm
5*4*3.5
differentiation
Low-Moderate
venous invasion
0
cirrhosis
0
afp ug l
110.2
ca199 u ml
14.66
cea ug l
3.13
library count
1
library sample ids
A052_HCC
total reads
505311559
source reference
Xue et al., Nature 612, 141-147 (2022), Supplementary Table 1
data accession
PRJCA007744
article url